Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Matthew Seymour, MD: A Clinical Trialist’s Perspective

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




May
01
Today In Oncology
Propofol Exposure and Neurocognitive Outcomes in Children With High-Risk ALL
Trends in Hematopoietic Cell Transplantation Survival Rates Across Racial and Ethnic Groups
USPSTF Issues Final Recommendation Statement on Screening for Breast Cancer
Combination of Preketone Supplements and Immunotherapy May Be Effective in Patients With Prostate Cancer
Neoadjuvant Chemoimmunotherapy in Patients With Early-Stage NSCLC
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside